704
Views
2
CrossRef citations to date
0
Altmetric
EDITORIAL

NACP 2014 and the Turku PET symposium: The interaction between therapy and imaging

, &
Pages 993-996 | Received 29 Jun 2014, Accepted 30 Jun 2014, Published online: 21 Aug 2014

References

  • Grau C, Høyer M, Alber M, Overgaard J, Lindegaard JC, Muren LP. Biology-guided adaptive radiotherapy (BiGART) – more than a vision? Acta Oncol 2013;52:1243–7.
  • Muren LP, Petersen JB, Hansen J, Hafslund R. Medical physics in the Nordic countries: The past, the present and the future (editorial). Acta Oncol 2009;48:165–8.
  • Muren LP and Glimelius B. And they lived happily ever after… The marriage of the Nordic Association for Clinical Physics and Acta Oncologica (editorial). Acta Oncol 2011; 50:835–7.
  • Glimelius B. Life of Pi. Acta Oncol 2011;50:1139–41.
  • Vestergaard A, Muren LP, Lindberg H, Jakobsen KL, Petersen JBB, Elstrøm UV, et al. Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer. Acta Oncol 2014;53:997–1004.
  • Gasic D, Ohlhues L, Brodin LN, Fog LS, Pommer T, Bangsgaard JP, et al. A treatment planning and delivery comparison of volumetric modulated arc therapy with or without flattening filter for gliomas, brain metastases, prostate, head/neck and early stage lung cancer. Acta Oncol 2014;53:1005–11.
  • Palmqvist T, Dybdahl Wanderås A, Langeland Marthinsen AB, Sundset M, Langdal I, Danielsen S, et al. Dosimetric evaluation of manually and inversely optimized treatment planning for high dose rate brachytherapy of cervical cancer. Acta Oncol 2014;53:1012–18.
  • Wright P, Suilamo S, Lindholm P, Kulmala J. Isocentric integration of intensity-modulated radiotherapy with electron fields improves field junction dose uniformity in postmastectomy radiotherapy. Acta Oncol 2014;53:1019–26.
  • Thorsen LBJ, Thomsen MS, Berg M, Jensen I, Josipovic M, Overgaard M, et al. CT-planned internal mammary node radiotherapy in the DBCG-IMN study: Benefit versus potentially harmful effects. Acta Oncol 2014;53:1027–34.
  • Lindblom E, Dasu A, Lax I, Toma-Dasu I. Survival and tumour control probability in tumours with heterogeneous oxygenation: A comparison between the linear-quadratic and the universal survival curve models for high doses. Acta Oncol 2014;53:1035–40.
  • Ardenfors O, Josefsson D, Dasu A. Are IMRT treatments in the head and neck region increasing the risk of secondary cancers? Acta Oncol 2014;53:1041–7.
  • Stokkevåg CH, Engeseth GM, Ytre-Hauge KS, Röhrich D, Odland OH, Muren LP, et al. Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. Acta Oncol 2014; 53:1048–57.
  • Casares-Magaz O, Toftegaard J, Muren LP, Kallehauge JF, Bassler N, Poulsen PR, et al. A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer. Acta Oncol 2014;53:1058–63.
  • Higgins CB, Hricak H, Gamsu G, Webb RW, Moss AA, Genant HK, et al. Clinical nuclear magnetic resonance imaging of the body. Semin Nucl Med 1983;13:347–63.
  • Khoo VS, Dearnaley DP, Finnigan DJ, Padhani A, Tanner SF, Leach MO. Magnetic resonance imaging (MRI): Considerations and applications in radiotherapy treatment planning. Radiother Oncol 1997;42:1–15.
  • Korsager AS, Stephansen UL, Carl J, Østergaard LS. The use of an active model for automated prostate segmentation in magnetic resonance. Acta Oncol 2013;52:1374–7.
  • Borren A, Groenendaal G, Moman MR, Boeken Kruger AE, van Dienst PJ, van Vulpen M et al. Accurate prostate tumour detection with multiparametric magnetic resonance imaging: Dependence on histological properties. Acta Oncol 2014;53:83–95.
  • Zilli T, Jorcano S, Peguret N, Caparrotti F, Hidalgo A, Khan HG, et al. Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis. Acta Oncol 2014;53:96–102.
  • Ravn S, Holmberg M, Sørensen P, Frøkjær JB, Carl J. Differences in supratentorial white matter diffusion after radiotherapy – new biomarker of normal brain tissue damage? Acta Oncol 2013;52:1314–9.
  • Kallehauge JF, Tanderup K, Duan C, Haack S, Pedersen EM, Lindegaard JC, et al. Tracer kinetic model selection for dynamic contrast enhanced magnetic resonance imaging of locally advanced cervical cancer. Acta Oncol 2014;53: 1064–72.
  • Haack S, Kallehauge JF, Jespersen SN, Lindegaard JC, Tanderup K, Pedersen EM. Correction of diffusion weighted magnetic resonance imaging for brachytherapy of locally advanced cervical cancer. Acta Oncol 2014;53:1073–8.
  • Ter-Pogossian MM. The origins of positron emission tomography. Semin Nucl Med 1992;22:140–9.
  • Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002;2:683–93.
  • Krause BJ, Schwarzenböck S, Souvatzoglou M. FDG PET and PET/CT. Recent Results Cancer Res 2013;187: 351–69.
  • Kiviniemi A, Gardberg M, Autio A, Heuser VD, Liljenbäck H, Käkelä M, et al. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies. Acta Oncol 2014;53:1125–34.
  • Busk M, Jakobsen S, Horsman MR, Mortensen LS, Iversen AB, Overgaard J, et al. PET imaging of tumor hypoxia using F-labeled pimonidazole. Acta Oncol 2013;52:1300–7.
  • Mönnich D, Troost EGC, Kaanders JHAM, Oyen WJG, Alber M, Zips D, et al. Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images. Acta Oncol 2013;52:1308–13.
  • Rusten E, Rodal J, Bruland OS, Malinen E. Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy. Acta Oncol 2013;52:1378–83.
  • Harteela M, Hirvi H, Mäkipää A, Teuho J, Koivumäki T, Mäkelä MM, et al. Comparison of end-expiratory respiratory gating methods for PET/CT. Acta Oncol 2014;53:1079–85.
  • von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: Current applications and future directions. Radiology 2006;238:405–22.
  • Leijenaar RTH, Carvalho S, Velazquez ER, van Elmpt WJC, Parmar C, Hoekstra OS, et al. Stability of FDG-PET radiomics feature: An integrated analysis of test-retest and inter-observer variability. Acta Oncol 2013;52:1391–7.
  • Carvalho S, Leijenaar RTH, Valazquez ER, Oberije C, Parmar C, van Elmpt WJC, et al. Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer. Acta Oncol 2013;52:1398–404.
  • Hoeben BAW, Bussink J, Troost EGC, Oyen WJG, Kaanders JHAM. Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer. Acta Oncol 2013;52:1257–71.
  • Kristian A, Revheim MA, Qu H, Maelandsmo GM, Engebraten O, Selerstad T, et al. Dynamic 18F-FDG-PET for monitoring treatment effect following antiangiogenic therapy in triple-negative breast cancer xenografts. Acta Oncol 2013;52:1566–72.
  • Kristian A, Riss P, Qu H, Milde M, Schoultz BW, Engebraaten O, et al. Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts. Acta Oncol 2014;53:1086–92.
  • Rødal J, Rusten E, Soevik A, Skogmo HK, Malinen E. Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy. Acta Oncol 2013;52:1293–9.
  • Koolen BB, van der Leij F, Vogel WV, Rutgers EJT, Vrancken Peeters M-JTFD, Elkhuizen PHM, et al. Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer. Acta Oncol 2014;53:50–7.
  • Revheim M-E, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, et al. Multimodal functional imaging for early response assessment in GIST patients treated with imatinib. Acta Oncol 2014;53:143–8.
  • Wu X, Pertovaara H, Korkola P, Vornanen M, Järvenpää R, Dastidar P, et al. Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma. Acta Oncol 2014;53:1093–9.
  • Schmid MP, Fidarova E, Pötter R, Petric P, Bauer V, Woehs V, et al. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervicx cancer radiotherapy. Acta Oncol 2013;52:1384–90.
  • Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013;52:1510–9.
  • Leibfart S, Mönnich D, Welz S, Siegel C, Schwenzer N, Schnidt H, et al. A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning. Acta Oncol 2013;52:1353–9.
  • Johansson A, Garpebring A, Karlsson M, Asklund T, Nyholm T. Improved quality of computed tomography substitute derived from magnetic resonance (MR) data by incorporation of spatial information – potential application for MR-only radiotherapy and attenuation correction in positron emission tomography. Acta Oncol 2013;52:1369–73.
  • Korhonen J, Kapanen M, Keyriläinen J, Seppälä T, Tuomikoski L, Tenhunen M. Influence of MRI-based bone outline definition errors on external radiotherapy dose calculation accuracy in heterogeneous pseudo-CT images of prostate cancer patients. Acta Oncol 2014;53:1100–6.
  • Malinen E, Muren LP. Image guided therapy – Do we get the picture? Acta Oncol 2014;53:3–5.
  • Stoiber EM, Schwarz M, Debus J, Bendl R, Giske K. An optimised IGRT correction vector determined from a displacement vector field: A proof of principle of a decision-making aid for re-planning. Acta Oncol 2014;53:33–9.
  • Elstrøm UV, Olsen SRK, Muren LP, Petersen JBB, Grau C. The impact of CBCT reconstruction and calibration for radiotherapy planning in the head and neck region – a phantom study. Acta Oncol 2014;53:1114–24.
  • Josipovic M, Persson GF, Håkansson K, Damkjaer SMS, Bangsgaard JP, Westman G, et al. Deep inspiration breath hold radiotherapy for locally advanced lung cancer: Comparison of different treatment techniques on target coverage, lung dose and treatment delivery time. Acta Oncol 2013; 52:1582–6.
  • Worm ES, Høyer M, Fledelius W, Hansen AT, Poulsen PR. Variations in magnitude and directionality of respiratory target motion throughout full treatment courses of stereotactic body radiotherapy for tumors in liver. Acta Oncol 2013; 52:1437–44.
  • Nielsen MS, Nyström MW, Carl J. Potential position errors using fiducial markers for gated image guided radiotherapy. Acta Oncol 2013;52:1472–6.
  • Schmidt ML, Hoffmann L, Kandi M, Moller DS, Poulsen PR. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer. Acta Oncol 2013;52:1490–6.
  • Schmidt ML, Poulsen PR, Toftegaard J, Hoffmann L, Hansen D. Clinical use of iterative 4D-cone beam computed tomography reconstructions to investigate respiratory tumor motion in lung cancer patients. Acta Oncol 2014;53:1107–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.